ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

KMK Kromek Group Plc

7.25
0.40 (5.84%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.40 5.84% 7.25 7.00 7.50 7.25 6.85 6.85 1,554,889 16:18:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Miscellaneous Metal Ores,nec 17.31M -6.1M -0.0102 -7.11 43.52M
Kromek Group Plc is listed in the Miscellaneous Metal Ores sector of the London Stock Exchange with ticker KMK. The last closing price for Kromek was 6.85p. Over the last year, Kromek shares have traded in a share price range of 3.15p to 8.55p.

Kromek currently has 600,247,000 shares in issue. The market capitalisation of Kromek is £43.52 million. Kromek has a price to earnings ratio (PE ratio) of -7.11.

Kromek Share Discussion Threads

Showing 6226 to 6244 of 7250 messages
Chat Pages: Latest  254  253  252  251  250  249  248  247  246  245  244  243  Older
DateSubjectAuthorDiscuss
29/3/2022
10:00
8days till another Kromek deadline passes with the traditional failure to acknowledge, explain or apologise.

Previously I had thought no PLC company would behave in such a dishonourable manner. However, it’s seems standard modus operandi for Kromek

aqc888
26/3/2022
07:27
Share price actually went down last time an ‘upto’ contract was announced after previous ‘upto’ failures. 11days till another Kromek deadline passes with the traditional failure to acknowledge, explain or apologise.
aqc888
25/3/2022
07:08
Kromek has no credibility left and soon (June- Charlie Buckets prediction) will have no money left either. Question is; are there enough mugs out there to partake in another fundraising, after all the previous ones which have proved to be nonsense… Could be at the end of the road and insolvent this time next year… they need to accelerate plans to sell parts of business, without a sale it’s over, a fact any buyer will be keen to exploit
aqc888
23/3/2022
19:21
Sorry

The science is evasive, which means only one thing.

IMO GLA

simithy
23/3/2022
19:04
Only good thing about Kromek is that the market thinks they are utterly hopeless, incompetent and worthless.

If they can prove they are just mostly hopeless, mostly but not always useless and have an ounce of real value somewhere - the share price might surge briefly…

A pivotal year as ST says. I think that’s his final call on Kromek. After the ‘pivotal year’ is over Kromek will be cut loose from their only supporter and shall be drifting with zero hope.

aqc888
23/3/2022
18:29
As an anecdote- Dragons’ Den seem to respect anyone who puts their life style on line for something they truly believe in - like remortgaging their properties.

Any evidence of that here?

IMO DYOR.

GLA

simithy
23/3/2022
17:57
Notwithstanding not having any scientific retort, are the Directors still paying themselves at top whack while they can?

Maybe stretching out the cash flow might buy some time?

simithy
23/3/2022
08:38
There is also a serious disconnect with his shareholders.
He should also take a look at these blog boards to see what his shareholders think of him!
But then again……… is he bothered about us? Don’t think so.

b00mb0y
23/3/2022
07:31
He needs to own a decent stake in his business he founded or step aside. How can any investor have faith in a business which does not have the belief of the founder and ceo. Step aside or invest Arnab.
aqc888
23/3/2022
07:12
Arnab, please look at the share price. It is screaming strategic review. There is a serious disconnect between the value of the business and the stock market valuation. You need to stop chasing rainbows
slicethepie
22/3/2022
21:33
How low can this go?
b00mb0y
22/3/2022
20:30
“March deadline may come and go…”

“That’s the risk we take”

A ridiculous point of view - the risk you’re taking is on the investment in the science. The risk you’re taking should NOT be the risk of the management feeding you complete rubbish repeatedly.

With Kromek you’re taking a risk on the science BUT with an extra layer of risk that the management will be fiddling all the facts/making up deadlines/ forgetting targets deadlines promises etc etc etc.

How can you assess risk when you’re never given the correct facts. Eg Detector works but can’t give the details of the accreditation etc etc. Eg trials are all great - but can’t tell you any details etc.

Its like an insurance company trying assess a risk when they are fed incorrect information. Most would refuse to quote. Most fund managers likewise refuse to invest in Kromek. Simply not a credible company. The proof of that is the FOUNDER & CEO owning a tiny minuscule percentage.

aqc888
22/3/2022
13:48
Just had to read it... the end of March may well come-and-go, but that was part of the risk we all knew and still know. Meanwhile we didn't ramp it to high heaven and then crash like Icarus!
dougmachin
18/3/2022
21:26
Two weeks till the self imposed deadline expires for sales of the full spectrum biological pathogen detector. They were supposedly in “serious discussions with multiple governments” - according to the CEO. Will anything come of it? Or will the deadline come and go with never another mention by the board. Just like so many other times… The never ending hunt for the end of the Kromek rainbow…
aqc888
17/3/2022
19:39
The one step forward two steps back scenario just been demonstrated. Hmmm, wonder why I don’t listen to myself? Haha.
b00mb0y
16/3/2022
17:16
Yes. Up it is! But beware of the one step forward two steps back malarkey.
b00mb0y
16/3/2022
13:38
Even KMK's up today!
dougmachin
11/3/2022
04:39
Look at this "AQC" post from late Jan. What changed? Did Basu wear you down like the rest of us?

"The Simon Thompson tip will give the share price a good boost tomorrow 5-10% I presume, the print edition will be published on Friday, hopefully cementing tomorrow’s boost.

I really wouldn’t rule Kromek out of featuring in the early feb bargain shares edition - which would see further and much bigger gains. 2022 is looking like the year it could all come together. Very limited downside especially at 15p and huge potential gains on x3 fronts in 2022, any one of which could multiply Kromeks share price - nuclear detector sales, biological pathogen detector governmental sales and sale of part of business."

ark87
11/3/2022
04:03
Simon Thompson Tick Tock getting close to that April deadline.

"Firstly, during our results call, chief executive Arnab Basu revealed that he expects first commercial sales by April for Kromek’s bio-security pathogen detectors"

ark87
Chat Pages: Latest  254  253  252  251  250  249  248  247  246  245  244  243  Older

Your Recent History

Delayed Upgrade Clock